TrialFrontiers in endocrinology2022

Comparison of empagliflozin and vildagliptin for efficacy and safety in type 2 diabetes mellitus in the Pakistani population.

Asima Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.